Website value calculator & SEO Checker => bioclever.com

Q: What IP bioclever.com has?

The domain bioclever.com has IP 46.16.63.95 . An IP address is a string of numbers used to make devices accessible for communication.

SEO report with information and free domain appraisal for bioclever.com. It is a domain hosted in . Its server is hosted on IP 46.16.63.95. The domain is ranked at the number 7215959 as a world ranking of web pages. According to estimated data we have access to potential gains of this site are 7 dollars per month. In annual terms, the domain bioclever.com could be earning more than 88 dollars. If someone wanted to buy the domain a good selling price would be 880 dollars.

These data are estimated and can not be taken as 100 % real. Only give an estimate of profits depending on the subject and the traffic generated by bioclever.com . The estimated number of unique visitors accessing bioclever.com is 64. Thus the total number of people who visit this page per month would be 1923 people.

Domain Authority

SEO Score

☰ Report Resume

SEO score
Speed
Page Load Time
Current Ip of the domain: 46.16.63.95
Charset of page: UTF-8
Total Keywords: 304
Total Links:

Anchor text
Type
Link
More information
follow
cookies-policy

follow
index.html
Request information
follow
contact
ES
follow
https://www.bioclever.com/es-ES/inicio
Home
follow
index.html
Our Values
follow
about-us
Our Mission
follow
our-mission
Quality Overview
follow
quality-overview
News
follow
news
Types of studies
follow
types-of-studies-cs-2-en
Clinical Trials
follow
clinical-trials-s-1-en
Observational Studies
follow
observational-studies-s-2-en
Nutritional Studies
follow
nutritional-studies-s-3-en
Medical Device Trials
follow
medical-device-trials-s-12-en
Clinical Research Services
follow
clinical-research-services-cs-3-en
Project Management
follow
project-management-s-4-en
Start up and Study design
follow
start-up-and-study-design-s-5-en
Data Management
follow
data-management-s-6-en
Biostatistics
follow
biostatistics-s-7-en
Medical Writing
follow
medical-writing-s-8-en
Pharmacovigilance
follow
pharmacovigilance-s-9-en
Clinical Quality Assurance
follow
clinical-quality-assurance-s-10-en
Monitoring
follow
monitoring-s-11-en
EDC
follow
edc-cs-4-en
CDISC. Data Standardization
follow
cdisc-data-standardization-cs-5-en
Personal Leasing
follow
personal-leasing-cs-6-en
Investigators
follow
investigators
Contact
follow
contact
Clinical Research Services
follow
clinical-research-services-cs-3-en
EDC
follow
edc-cs-4-en
CDISC. Data Standardization
follow
cdisc-data-standardization-cs-5-en
Personal Leasing
follow
personal-leasing-cs-6-en
Meet us
follow
about-us
See all
follow
news

follow
statistics-in-clinical-trials-n-47-en
Statistics in Clinical Trials
follow
statistics-in-clinical-trials-n-47-en

follow
statistics-in-clinical-trials-n-47-en

follow
duration-of-clinical-trials-and-observational-studies-n-46-en
Duration of Clinical Trials and Observational Studies
follow
duration-of-clinical-trials-and-observational-studies-n-46-en

follow
duration-of-clinical-trials-and-observational-studies-n-46-en

follow
taking-part-in-clinical-trial-what-you-must-know-n-45-en
Taking part in a clinical trial: What you must know
follow
taking-part-in-clinical-trial-what-you-must-know-n-45-en

follow
taking-part-in-clinical-trial-what-you-must-know-n-45-en
Our Values
follow
about-us
Our Mission
follow
our-mission
Quality Overview
follow
quality-overview
Contact
follow
contact
News
follow
news
Clinical Trials
follow
clinical-trials-s-1-en
Observational Studies
follow
observational-studies-s-2-en
Nutritional Studies
follow
nutritional-studies-s-3-en
Medical Device Trials
follow
medical-device-trials-s-12-en
Project Management
follow
project-management-s-4-en
Start up and Study design
follow
start-up-and-study-design-s-5-en
Data Management
follow
data-management-s-6-en
Biostatistics
follow
biostatistics-s-7-en
Medical Writing
follow
medical-writing-s-8-en
Pharmacovigilance
follow
pharmacovigilance-s-9-en
Clinical Quality Assurance
follow
clinical-quality-assurance-s-10-en
Monitoring
follow
monitoring-s-11-en
[email protected]
follow
mailto:[email protected]
[email protected]
follow
mailto:[email protected]

follow
https://www.facebook.com/BioClever-1552072425005553/

follow
https://twitter.com/bioclevercro

follow
https://www.linkedin.com/company/bioclever-2005
Legal notice
follow
legal-notice
Privacy policy
follow
privacy-policy
Cookies Policy
follow
cookies-policy
Web design
follow
https://www.latevaweb.com/

follow
tel:934086388
Social signals
Title: 60 characters.
Description: 151 characters.
Domain Authority
Monthly pages viewed: 1923
Estimated worth: 880 dollars

☷ Major sections

❀ Whois

We have developed a useful service for retrieve WhoIs information. "Whois" is a term that begins from the early days of the Internet, based on Unix operating system and university networks. On the Unix console, the command "whois" tries to determine the identity of the domain's registrant.

It is a means for Internet users to query various types of information such as IP addresses, user data and also domain data.

✦ SEO Report

Title / Meta tags

CRO BioClever | Clinical trials in Spain (Barcelona, Madrid)

We are a CRO specialized in clinical trials and observational studies, which offers its services in Barcelona, Madrid and the entire national territory

Image Analysis

A right example for an HTML image tag:

For SEO performance, you must write an alternative text. The alternative text must describe the image's content. Also, the alt tag is used for blind people. Their browsers tell them all about the description of the image.

Heading

Content Analysis

Code Analysis

We have not found hyphens (-) or underscores (_) in your URL. Google and expert domainers do not recommend buying domains with hyphens or underscores.

☛ Speed Analysis

When a visitor came to your website you can not fail. The user wants your page to load in a second. You know that it is difficult sometimes to display content in the first second but if the user has to wait too much time you can lose that user. If your page is too slow, you will lose a lot of web traffic. Your project URL load time is ms, it is class speed. This speed not fine and need to be improved. It is over the average. Our Speed analyzer has shown that www.bioclever.com is as follows:

A huge portion of visitors to your website are usually in rush and nobody is fond of waiting too much before your website loads its content. If your website is slow, you will lose a lot of visitors. Your homepage load time is ms is class speed. This speed not fine and need to be improved. It is over the average. Our Speed analyzer has shown that www.bioclever.com is as follows:

Speed:

Page Load Time: ms

⚐ Page Analysis

⚏ CSS Class names

home, fixed flex items-center bottom-0 left-0 w-full sm:pb-3 sm:px-3 z-40, flex flex-wrap lg:flex-no-wrap items-center justify-around lg:justify-between p-3 w-full bg-gray-700 sm:rounded text-gray-100, mb-0 mx-3 text-sm, button-ghost text-sm cursor-pointer border-white mt-3 lg:mt-0, fixed flex items-center w-full h-16 md:h-24 bg-gray-100 z-50 shadow-md, w-full md:px-10 lg:px-20 ml-4 flex justify-between items-center, w-20 md:w-32, button-primary inline-block ml-auto sm:mr-16, menu__icon ml-3 md:ml-8 cursor-pointer, text-gray-900 w-8 h-8 mr-3, menu menu-right w-full max-w-xl, menu__close absolute top-0 right-0 mt-4 mr-4 md:mt-12 md:mr-24, text-gray-600 w-6 h-6 cursor-pointer, flex items-center, lang flex items-center ml-6 mt-6, flex items-center leading-none no-underline uppercase, text-sm text-white underline, lang__menu flex items-center, block ml-3 text-sm text-white no-underline hover:text-white hover:underline, w-full p-12 md:py-20 md:pl-24, menu__list, active menu__item, dropdown menu__item relative, third-level list-none w-full p-0 m-0, menu__item, second-level list-none w-full p-0 m-0, generalContent pt-12 md:pt-24 bg-white, relative bg-white z-10, relative overflow-hidden, , w-full, container absolute px-12 sm:px-4 sm:mt-0 bottom-0 md:bottom-24 left-1/2 transform -translate-x-1/2, font-display text-2xl md:text-4xl text-white text-display mb-0, lg:w-2/3 mb-6 md:mb-12 text-base md:text-3xl mt-0, text-white mb-4, relative z-20 md:-mt-12, container mx-auto px-6 md:px-3 lg:rounded-b-lg overflow-hidden bg-white custom-shadow, flex flex-wrap justify-center items-stretch -mx-3, group w-full sm:w-1/2 md:w-1/5 flex flex-col items-center text-center bg-gray-100 p-6 mb-1 md:mb-0 md:border-r md:border-gray-200 md:hover:bg-primary-400 cursor-pointer, md:group-hover:text-black w-12 h-12 text-primary-500, pt-3 normal-case font-bold text-center, group w-full sm:w-1/2 md:w-1/5 flex flex-col items-center text-center bg-gray-100 p-6 mb-1 md:mb-0 md:hover:bg-primary-400 cursor-pointer, mt-12 py-12 lg:py-40 capabilities, mx-auto px-3 md:px-32, mx-auto px-3 sm:px-16 py-12 bg-black bg-opacity-50 shadow-lg rounded-xl relative, mt-0 text-center text-white, my-4 px-4 text-center text-white max-w-4xl mx-auto, flex flex-wrap, w-full md:w-1/2 my-4 px-4, block button-primary w-full text-center max-w-sm mx-auto, py-24, container mx-auto px-6 md:px-3, md:w-11/12 mx-auto, flex flex-wrap -mx-3, w-full md:w-1/2 lg:w-3/5 px-3 responsive-container md:order-2, absolute inset-0 w-full h-full rounded-lg shadow-lg border-0, w-full md:w-1/2 lg:w-2/5 mt-4 md:mt-0 px-3 md:order-1, font-extrabold pr-6, mb-8, button-primary, w-6 inline-block ml-6, pt-12 bg-gradient-gray-white, sm:w-11/12 mx-auto px-3 sm:px-16 py-12 bg-white shadow-lg rounded-xl -mb-16 relative, flex justify-between items-center, mt-0, button-primary text-center, flex flex-wrap -mx-3 listado-noticias, w-full sm:w-1/2 md:w-1/3 mb-6 px-3, flex flex-col items-stretch h-full, rounded-lg shadow-md, flex flex-wrap h-full, mt-3, text-base font-bold normal-case mt-0 mb-3, text-primary-900, text-sm, w-full self-end, w-6 inline-block mt-3, pt-32, w-full md:w-1/4 mb-6 md:mb-0, mx-auto w-24 md:w-32 xl:w-40, my-24, mx-auto w-24 md:w-32 xl:w-40 mb-6, flex flex-wrap w-full md:w-3/4, w-full md:w-1/3 mb-6 md:mb-10, list-none, font-bold uppercase mb-2, bg-gray-700 pt-6, container mx-auto px-6 md:px-3 flex flex-wrap justify-between, w-full md:w-1/3 flex justify-center md:justify-end mb-6 md:order-2, text-white hover:text-primary-800 w-5 h-5 mx-2 facebook, text-white hover:text-primary-800 w-6 h-6 mx-2 twitter, text-white hover:text-primary-800 w-5 h-5 mx-2 linkedin, list-none w-full md:w-1/3 flex flex-wrap justify-center md:justify-start legal md:order-1, ml-1, phoneButton, social_whatsapp_w,

Ω HTTP Header Analysis

✪ Source Analysis

Your website is made from CSS files, images and javascript sources. We count all the files and their size. This is vital data about the performance of your website.